Introduction: Postanaesthetic shivering is a common condition after surgery which needs proper management with pharmacologic agents so as to make postoperative period comfortable to the patient and prevent from the untoward complications that can arise from it. This study was done to compare the effectiveness of Pethidine and Doxapram in the treatment of postanaesthetic shivering.
INTRODUCTION
Postanaesthetic shivering is a very common complication of general anaesthesia with a reported incidence varying from 5-65%. 1, 2 Patients report that shivering is remarkably uncomfortable, and some even fi nd it worse than surgical pain. 1 It is important to prevent or treat postanaesthetic shivering because of distress it causes to the patient and the consequences of which may sometimes be fatal.
Different methods have been used to treat postanaesthetic shivering till date. There are pharmacological and non pharmacological measures. Pharmacological measures includes agents like: doxapram, pethidine, amino acids, clonidine, metamizole, tramadol, nefopam, nalbuphine, physostigmine, ondansetron, fentanyl, alfentanyl, sufentanyl, and urapidil. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Non pharmacological measures like use of space blankets have also shown to decrease the incidence of postanaesthetic shivering. 17 Among many pharmacological agents, Pethidine and Doxapram have been found to be very effective in the control of postanaesthetic shivering. In this study, the effectiveness of Pethidine and Doxapram and placebo (normal saline) for control of post anaesthetic shivering in 30 patients (10 patients in each group) was compared.
METHODS
A prospective double blind study was conducted in Bir Hospital among patients who underwent surgery under general anesthesia and who developed shivering. Total of 30 patients with ASA (American Society of Anesthesiologists) physical status I and II who underwent general and orthopaedic surgeries were included in the study after obtaining institutional approval and written informed consent. Following patients were excluded: Patients were randomly divided into three groups, 10 in each. Randomization, allocation of drugs and placebo among the study patients were done by the anaesthetic nurse, keeping the principal researcher unaware of the drug and placebo assignment. Group I received 1.5mg/ kg body wt. of Doxapram, Group II received 0.35mg/ kg body wt. of Pethidine and Group III received normal saline in equal volume of 3ml injectable solutions. All patients who underwent surgery were premedicated with diazepam 5mg (in patients <50kg body wt) and 10mg (in patients >50kg body wt.) orally at night.
After receiving the patient in operation theatre an intravenous line was secured, and continuous monitoring (ECG, pulseoximetry, NIBP, thermometer) was started. Anaesthesia was induced with Sodium thiopentone 5mg/kg, Pethidine (0.5 mg/kg) was given for analgesia and Succinylcholine 1.5mg/kg was given to facilitate intubation. Anaesthesia was maintained with Halothane, Pancuronium and Pethidine as and when needed. After completion of surgery, effects of muscle relaxants was reversed with Neostigmine 0.05mg/kg and atropine 0.02mg/kg and extubated after adequacy of ventilation was confi rmed.
Operation theatre temperature was maintained at 18ºC. Temperature of IV fl uids was warmed up to 18ºC. Patients were observed by investigator for 30 minutes inside the operating room after reversal of anaesthesia and occurrence of shivering within this period was observed, scored and treated.
The investigator who gave the injection was unaware of the nature of the drug received by the unaware patient from identical syringes containing either Normal saline, Doxapram or Pethidine with equal volume prepared by anaesthetic nurse.
Shivering grade scoring was done according to the shivering grade given in the table (Table1). Grading was done before the test drug was given and then at every subsequent two minutes after treatment for 10 minutes with other monitored data in specially formulated data collection form. Level of monitoring at recovery room was also the same as in operation theatre. Statistical analysis of data collection was done by using ANOVA test (analysis of variance test) for comparison of means between the different groups with regard to age, weight, duration of anaesthesia, heart rate and systolic and diastolic arterial blood pressure and peripheral body temperature.
RESULTS
Among thirty studied patients, ten in each group: in group I, six out of ten who received Doxapram stopped and four continued shivering. In group II, eight patients stopped shivering who received Pethidine and in group III only two who received normal saline stopped shivering and eight continued. So the effectiveness of Pethidine was found signifi cantly higher as compared to normal saline.
Statistically the results between Normal saline and Pethidine was found signifi cant as P<0. Among thirty patients, 6 out of 10 stopped shivering in group I. In Group II, 8 out of 10 stopped shivering and in Group III, only 2 out of 10 stopped shivering. So the effectiveness of Pethidine was found signifi cantly higher as compared to normal saline ( Table 5) .
The results between Normal saline and Pethidine was found signifi cant (P<0.05). However, the results between Doxapram and Normal saline P>0.05; and between Pethidine and Doxapram (P>0.05) were not signifi cant statistically. 
DISCUSSION
Postanaesthetic shivering is a very common complication of general anaesthesia with a reported incidence varying from 5 to 65 %. Patients report that shivering is remarkably uncomfortable and some even fi nd it worse than surgical pain. 2 This study showed that both Pethidine and Doxapram were effective in controlling postanaesthetic shivering but there was no statistically signifi cant between the two. However, Pethidine was found more effective as the shivering was controlled in 8 patients compared to 6 in case of Doxapram. Many studies done so far also document Pethidine more effective and superior to Doxapram for the control of postanaesthetic shivering. In a study of group of patients who developed postanaesthetic shivering after receiving inhalational anaesthesia found a signifi cantly higher proportion of patients stopped shivering after being given Doxapram than after placebo. 2 Similarly one study which compared the effectiveness of Doxapram and Pethidine in the treatment of post-anaesthetic shivering with saline as placebo found that Doxapram and Pethidine were both effective in controlling shivering. In Doxapram group, 85% (n=17) of patients stopped shivering within 10 minutes whereas in Pethidine group 100% (n=20) of patients stopped shivering with only 25%(n=5) in control group. 1 In another study done in 220 healthy patients who shivered following routine surgery on the minimum effective doses of Pethidine and Doxapram in the treatment of post-anaesthetic shivering and concluded that 0.35mg/kg of Pethidine is the minimum dose required to treat postanaesthetic shivering effectively. They also concluded that 0.18mg/kg of Doxapram is as effective as 1.4mg/kg in the treatment of postanaesthetic shivering. 18 Shivering is one of the mechanisms to increase body temperature which is mediated by the primary motor center in the hypothalamus in response to the cold signals from the skin and spinal cord. 19 The integrity and effectiveness of the thermoregulatory system is adversely affected by several factors including age, disease, injury, and various pharmacologic agents. Specifi cally anaesthetics have been shown to inhibit thermoregulatory control in animals and humans. As a result, anaesthetized patients often become hypothermic during surgery. Perioperative hypothermia may predispose to complications including postoperative shivering, impaired coagulation, decreased cutaneous blood fl ow, slowed drug metabolism, and decreased resistance to surgical wound infection. 20 Exact mechanism of how Pethidine controls postanaesthetic shivering is not well documented. Recently it has been found that its antishivering properties are related to its binding with kappa receptors and specifi c actions on temperature regulation centers in the hypothalamus. In one study, the antishivering activity of Pethidine was minimally impaired by low-dose Naloxone (blocking most mu-receptors), but largely prevented by high-dose Naloxone (blocking all mu and most kappa receptors) 21 thus attributing kappa receptors as the site of action of Pethidine for the control of shivering. It has some spasmogenic effect on certain smooth muscles as well.
Besides pharmacological methods, non pharmacological methods like space blanket have been used which also decreases the incidence of postanaesthetic shivering.
CONCLUSIONS
Even though there are many pharmacological and non pharmacological methods, Pethidine is one of the best pharmacological agents for the control of postanaesthetic shivering and has been found superior to Doxapram in this study.
